SUN Pharmaceutical Industries Limited — Glimepiride Exporter Profile
Indian Pharmaceutical Exporter · #6 for Glimepiride · $1.6M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #6 Indian exporter of Glimepiride with $1.6M in export value and 66 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.0% market share in Glimepiride exports across 4 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Glimepiride Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Glimepiride?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $757.2K | 28 | 58.4% |
| MYANMAR | $467.4K | 34 | 36.0% |
| PERU | $64.2K | 4 | 5.0% |
| KENYA | $7.7K | 2 | 0.6% |
SUN Pharmaceutical Industries Limited exports Glimepiride to 4 countries. The largest destination is TANZANIA accounting for 58.4% of SUN Pharmaceutical Industries Limited's Glimepiride shipments, followed by MYANMAR (36.0%) and PERU (5.0%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Glimepiride from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYIT MAHAR TRADING CO., LTD. | MYANMAR | $279.9K | 20 |
| TO THE ORDER OF | TANZANIA | $155.6K | 5 |
| I AND M BANK (T) LTD., | TANZANIA | $149.9K | 4 |
| MYIT MAHAR TRADING CO LIMITED | MYANMAR | $144.7K | 11 |
| AV REPUBLICA DPANAMA NO3418-3420 OF | PERU | $61.2K | 3 |
| ECO BANK | TANZANIA | $57.6K | 2 |
| BANK OF AFRICA TANZANIA LIMITEDP O BOX | TANZANIA | $50.0K | 1 |
| TO THE ORDER OF NATIONAL BANK OF CO | TANZANIA | $50.0K | 1 |
| TO THE ORDER OF ABSA BANK TANZANIA | TANZANIA | $50.0K | 1 |
| M/S. TO THE ORDER OF BANK OF AFRICA | TANZANIA | $27.7K | 1 |
SUN Pharmaceutical Industries Limited supplies Glimepiride to 18 buyers globally. The largest buyer is MYIT MAHAR TRADING CO., LTD. (MYANMAR), followed by TO THE ORDER OF (TANZANIA) and I AND M BANK (T) LTD., (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Glimepiride Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $23.4M worth of Glimepiride through 3,159 shipments from 242 suppliers to 94 countries, serving 535 buyers globally. SUN Pharmaceutical Industries Limited contributes $1.6M to this total, accounting for 2.0% of India's Glimepiride exports. SUN Pharmaceutical Industries Limited ships Glimepiride to 4 countries through 18 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Glimepiride Exports?
SUN Pharmaceutical Industries Limited's average Glimepiride shipment value is $23.6K per consignment, based on 66 shipments totaling $1.6M. The largest destination is TANZANIA (58.4% of SUN Pharmaceutical Industries Limited's Glimepiride exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Glimepiride Exporters?
SUN Pharmaceutical Industries Limited ranks #6 among 242 Indian Glimepiride exporters with a 2.0% market share. The top 3 exporters are MICRO LABS LIMITED ($5.3M), IPCA LABORATORIES LIMITED ($3.6M), INVENTIA HEALTHCARE LIMITED ($3.0M). SUN Pharmaceutical Industries Limited processed 66 shipments to 4 destination countries.
What Glimepiride Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GEMER 2 TABLETS (GLIMEPIRIDE AND EXTENDE | $180.3K | 6 |
| GEMER 2MG TABLETS (GLIMEPIRIDE 2MG AND EXTENDED RELEASE METFORMIN HYDROCHLORIDE500MG TABLETS) [36678 PACK X 3 X 10'S] ( | $61.2K | 3 |
| GEMER 2 TABLETS (GLIMEPIRIDE AND EXTENDED RELEASE METFORMIN HYDROCHLORI) PACK :BOX5X10SNOS | $53.3K | 2 |
| GEMER 2 TABLETSGLIMEPIRIDE AND EXTENDEDRELEASE METFORMIN HYDROCHLORISAP CODE:1119052 JME0722A MFD:08/2023 EXP.07/2025 | $50.0K | 1 |
| GEMER 2 TABLETS (GLIMEPIRIDE 2MG AND EXTENDED RELEASE MELFORMIN HCL.500MG TABLETS PACK: BOX5X10SNOS | $50.0K | 1 |
| GEMER 2 TABLETS (GLIMEPIRIDE AND EXTENDED RELEASE METFORMIN HYDROCHLORIDE 500MGTABLETS) PACK: BOX5X10SNOS | $50.0K | 1 |
| GEMER 2 TABLETS (GLIMEPIRIDE 2MG AND EXTENDED RELEASE METFORMIN HYDROCHLORIDE 500MG TABLETS) PACK BOX5X10SNOS | $50.0K | 1 |
| GEMER 2 TABLETS PACK: BOX 5X10s BATCH:JMG0047A,JMG0048A,JMG0049AGLIMEPIRIDE AND EXTENDED RELEASE METFORMIN HYDROCHLORID | $50.0K | 1 |
| GEMER 1 TABLETS (Glimepiride and Extende | $49.8K | 3 |
| GEMER 2 TABLETS(GLIMEPIRIDE AND EXTENDEDRELEASE METFORMIN HYDROCHLORI)SAP CODE: 1119052 PACK:BOX5X10S BNO.JMF0091A ** | $49.0K | 1 |
SUN Pharmaceutical Industries Limited exports 50 distinct Glimepiride formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GEMER 2 TABLETS (GLIMEPIRIDE AND EXTENDE with 6 shipments worth $180.3K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Glimepiride Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MEDREICH LIMITED | $2.1M | 42 | 1 | $50.0K |
| 1 | INDOCO REMEDIES LIMITED | $2.0M | 41 | 2 | $50.0K |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $1.6M | 66 | 4 | $23.6K |
| 8 | MYLAN LABORATORIES LIMITED | $1.3M | 86 | 4 | $14.8K |
| 9 | AJANTA PHARMA LIMITED | $1.2M | 41 | 3 | $28.4K |
SUN Pharmaceutical Industries Limited ranks #6 among 242 Indian Glimepiride exporters. Average shipment value of $23.6K compared to the market average of $96.6K. The closest competitors by value are MEDREICH LIMITED and INDOCO REMEDIES LIMITED.
Which Indian Ports Ship Glimepiride Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 350 | 11.1% |
| NHAVA SHEVA SEA (INNSA1) | 268 | 8.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 241 | 7.6% |
| DELHI AIR CARGO ACC (INDEL4) | 228 | 7.2% |
| DELHI AIR | 226 | 7.2% |
| JNPT/ NHAVA SHEVA SEA | 172 | 5.4% |
| BANGALORE ACC (INBLR4) | 148 | 4.7% |
| BANGALORE AIR | 110 | 3.5% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Glimepiride Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Glimepiride, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glimepiride — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Glimepiride shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 68 individual customs records matching SUN Pharmaceutical Industries Limited exporting Glimepiride, covering 50 formulations to 4 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 535+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Glimepiride Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Glimepiride exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Glimepiride Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glimepiride. For current shipment-level data, contact TransData Nexus.